Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR5A1 | Q13285 | 1/20 | 0.61 |
| ▸ | NPC1 | O15118 | 2/20 | 0.55 |
| ▸ | RAB9A | P51151 | 2/20 | 0.55 |
| ▸ | LTA4H | P09960 | 3/20 | 0.55 |
| ▸ | TP53 | P04637 | 2/20 | 0.54 |
| ▸ | TSHR | P16473 | 1/20 | 0.54 |
| ▸ | HPGD | P15428 | 1/20 | 0.54 |
| ▸ | PLA2G4B | P0C869 | 2/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11144854 | 1.00 | NR5A1 (0.61) | NR5A1NPC1RAB9ALTA4HTP53 | |
| SCHEMBL27560553 | 1.00 | NR5A1 (0.61) | NR5A1NPC1RAB9ALTA4HTP53 | |
| SCHEMBL14064703 | 1.00 | NR5A1 (0.61) | NR5A1NPC1RAB9ALTA4HTP53 | |
| SCHEMBL7763453 | 1.00 | NR5A1 (0.61) | NR5A1NPC1RAB9ALTA4HTP53 | |
| SCHEMBL9308805 | 1.00 | NR5A1 (0.61) | NR5A1NPC1RAB9ALTA4HTP53 | |
| SCHEMBL4809789 | 1.00 | NR5A1 (0.61) | NR5A1NPC1RAB9ALTA4HTP53 | |
| SCHEMBL9561907 | 1.00 | NR5A1 (0.61) | NR5A1NPC1RAB9ALTA4HTP53 | |
| SCHEMBL8532324 | 0.95 | RARB (0.58) | NR5A1NPC1RAB9ALTA4HTP53 | |
| SCHEMBL8533362 | 0.95 | RARB (0.58) | NR5A1NPC1RAB9ALTA4HTP53 | |
| SCHEMBL8759014 | 0.95 | RARB (0.58) | NR5A1NPC1RAB9ALTA4HTP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10188605-B2 | Nanoparticles and nanoparticle compositions | IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 2019-01-29 | — | — | US | disclosed |
| US-20160271061-A1 | NANOPARTICLES AND NANOPARTICLE COMPOSITIONS | IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. | 2016-09-22 | — | — | US | disclosed |
| US-9320713-B2 | Nanoparticles and nanoparticle compositions | IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 2016-04-26 | — | — | US | disclosed |
| US-20140308360-A1 | NANOPARTICLES AND NANOPARTICLE COMPOSITIONS | NATIONAL SCIENCE FOUNDATION | 2014-10-16 | — | — | US | disclosed |
| US-8790621-B2 | Nanoparticles and nanoparticle compositions | IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 2014-07-29 | — | — | US | disclosed |
| US-20130101516-A1 | NANOPARTICLES AND NANOPARTICLE COMPOSITIONS | IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 2013-04-25 | — | — | US | disclosed |
| WO-2011130114-A1 | NANOPARTICLES AND NANOPARTICLE COMPOSITIONS | IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 2011-10-20 | — | — | WO | disclosed |
| EP-0321984-B1 | MESOMORPHIC COMPOUND HAVING BETA-HYDROXYCARBOXYL GROUP AS CHIRAL SOURCE AND LIQUID CRYSTAL COMPOSITION | MITSUBISHI RAYON CO., LTD. (JP) | 1992-10-21 | — | — | EP | disclosed |
| US-4925591-A | FERROELECTRIC | MITSUBISHI RAYON CO., LTD. (JP) | 1990-05-15 | — | — | US | disclosed |
| EP-0321984-A1 | Mesomorphic compound having beta-hydroxycarboxyl group as chiral source and liquid crystal composition | MITSUBISHI RAYON CO., LTD. (JP) | 1989-06-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10188605-B2 | Nanoparticles and nanoparticle compositions | MCM6, MPI, MSH2 | NR5A1 4378/4885NPC1 3074/4885RAB9A 1195/4885 |
| US-20140308360-A1 | NANOPARTICLES AND NANOPARTICLE COMPOSITIONS | MCM6, MPI, MSH2 | NR5A1 4378/4885NPC1 3074/4885RAB9A 1195/4885 |
| US-20130101516-A1 | NANOPARTICLES AND NANOPARTICLE COMPOSITIONS | MCM6, MPI, MSH2 | NR5A1 4378/4885NPC1 3074/4885RAB9A 1195/4885 |
| US-20160271061-A1 | NANOPARTICLES AND NANOPARTICLE COMPOSITIONS | MCM6, MPI, MSH2 | NR5A1 4378/4885NPC1 3074/4885RAB9A 1195/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.